Geneuity® Clinical Research Services’ parent company, Molecular Pathology Laboratory Network, Inc. (MPLN), recently named Jason Jones the Chief Information Officer. Read the rest of this entry »
Dr. Neil Quigley, vice president of Geneuity® Clinical Research Services, recently gained licensure with the State of Tennessee as a Medical Laboratory Director in Molecular Diagnostics. Read the rest of this entry »
Molecular Pathology Laboratory Network, Inc. (MPLN) recently announced that the United States Patent and Trademark Office (USPTO) granted trademark registration for the name of one of its divisions, Geneuity® Clinical Research Services, effective on September 15, 2009. Read the rest of this entry »
Geneuity™ Clinical Research Services announces the recent validation and use in clinical trials of two human biomarker assays that play a key role in the early detection of kidney damage. Read the rest of this entry »
Ranee Taylor, PhD, director of business development for Geneuity Clinical Research Services, was recently named to the editorial advisory board for “Pharmaceutical Outsourcing.” Read the rest of this entry »
Molecular Pathology Laboratory Network, Inc. (MPLN), parent company to Geneuity Clinical Research Services, recently announced the redesign of its website, www.mplnet.com. Read the rest of this entry »
Geneuity ™ Clinical Research Services’ parent company, Molecular Pathology Laboratory Network Inc., (MPLN), will celebrate 20 years of success in the healthcare and molecular diagnostics industry on July 1, 2009. Read the rest of this entry »
Geneuity™ Clinical Research Services won first place in the Interactive Website competition during the 30th Annual Diagnostic Marketing Association (DxMA) Dx Communication Awards held in Chicago on March 18. Read the rest of this entry »
Geneuity™ Clinical Research Services is exhibiting at the 18th Annual Partnerships with CROs Conference in Orlando, Florida April 28-30, 2009. Read the rest of this entry »
The February 2009 issue of ASCP’s LabMedicine™ features an article about b-cell lymphoma with intermediate- to high- grade features and different immunophenotypic profiles involving separate anatomic sites with a good response to R-CHOP. Read the rest of this entry »